Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride recall — Integradose Compounding Services LLC (Class II)

Integradose Compounding Services LLC is recorded by the U.S. Food and Drug Administration (FDA) as recalling Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride — a Class II recall, initiated 2026-05-18 and posted to the FDA enforcement report on 2026-06-24, under recall number D-0593-2026. Status Ongoing, with no termination date on the record. The reason the FDA record carries is, verbatim: “Subpotent Drug”. From the product description, the strengths given are 2 Units/2 mL and 0.9%. 1 National Drug Code number is printed in the record: 71139-0190-1. Distribution is recorded as “U.S.A. Nationwide” — Nationwide (US), with the recalling firm on record in MN, United States. It is the only recall number the FDA has filed under event ID 99014. Integradose Compounding Services LLC accounts for 2 recall records in the indexed dataset. Values are reproduced from the linked openFDA report; regulatory information, not medical advice.

Regulatory snapshot

Recall number D-0593-2026
FDA event ID 99014
Classification Class II (intermediate regulatory tier)
Status Ongoing
Recalling firm Integradose Compounding Services LLC
Recall initiated 2026-05-18
Reported by FDA 2026-06-24
Report lag 37 days from initiation to report
Distribution U.S.A. Nationwide — Nationwide (US)
Firm location on record MN, United States
Product description (source) Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride, syringe, IntegraDose Compounding Services, LLC. 3650 Victoria St N, Suite 900, Shoreview, MN, NDC 71139-0190-1.

Reason reported by FDA

Subpotent Drug

2 words from the enforcement report field reason_for_recall, reproduced without edit — the firm's own wording, not an assessment.

Product identifiers in this record

3 identifying values matched by exact pattern in the 23-word product description above; each is a literal substring of it.

Product named Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride
Strength 2 Units/2 mL · 0.9%
NDC 71139-0190-1

Other indexed recalls from Integradose Compounding Services LLC

2 indexed records name Integradose Compounding Services LLC as the recalling firm, across 2 FDA events, reported 2026-05-27 to 2026-06-24. A coverage-limited activity count over the ingested window, not a quality rating.

Recall recordRecall numberFDA tierStrength / formReported
fentaNYL Citrate, 2,2500 mcg/50mLD-0548-2026Class II2,2500 mcg/50mL · for Injection2026-05-27

Reported in the same month (2026-06)

74 enforcement reports carry a report date in 2026-06; these 8 are the Class II ones nearest this record.

Recall recordRecall numberRecalling firmFDA tierReported
Alyacen 7/7/7, 0.5mg/0.035mgD-0588-2026Glenmark Pharmaceuticals Inc., UsaClass II2026-06-24
VistaPharm, 25 GramsD-0589-2026Pai Holdings LLCClass II2026-06-24
VistaPharm, 50 GramsD-0590-2026Pai Holdings LLCClass II2026-06-24
VistaPharm, 25 GramsD-0591-2026Pai Holdings LLCClass II2026-06-24
VistaPharm, 50 GramsD-0592-2026Pai Holdings LLCClass II2026-06-24
Aripiprazole Tablets USP, 30 mgD-0594-2026Ajanta Pharma Usa IncClass II2026-06-24
Buprenorphine HCl, 0.3 mg/mLD-0596-2026Par Health Usa, LLCClass II2026-06-24
Pearson Quality Topical Anesthetic Gel (20% Benzocaine)D-0600-2026Keystone IndustriesClass II2026-06-24

Nearest Class II recalls by date

213 of 250 indexed records share the Class II tier; the 7 nearest to 2026-06-24 by report date are listed here.

Recall recordRecall numberRecalling firmStrength / formReported
Quala Dental Products, 20 %D-0601-2026Keystone Industries20 % · Gel2026-06-24
DHP Topical Anesthetic Gel, 20%D-0602-2026Keystone Industries20% · Gel2026-06-24
Burkhart topical anesthetic gel, 20 %D-0603-2026Keystone Industries20 % · Gel2026-06-24
Dental City TOPICAL ANESTHETIC GEL, 20%D-0604-2026Keystone Industries20% · Gel2026-06-24
PureLife, 20%D-0605-2026Keystone Industries20% · Gel2026-06-24
safco SensiCaine-Ultra (20% Benzocaine)D-0606-2026Keystone Industries20% · Gel2026-06-24
Chlorthalidone Tablets, 25 mgD-0610-2026Inventia Healthcare Ltd25 mg · Tablets2026-06-24

Reading this record

Class II is the FDA's own severity tier for the recall action — 213 of the 250 indexed records carry it — and it describes the agency's assessment of the action, not a risk statement about any individual. Match a package against 71139-0190-1 at the FDA source to confirm it is covered.

Namespace context: the Class II index (213 records) and the recall hub (250 records, 118 FDA events); Integradose Compounding Services LLC (2 indexed records) aggregates this firm across datasets.

Coverage and limits of this record

This page reflects the openFDA enforcement report for D-0593-2026 as ingested on 2026-08-22, which can lag the live FDA record and omits detail held only in primary documents. It offers no clinical assessment, no advice about whether to use any product, and no substitute. For any health question consult a qualified healthcare professional.

Source & provenance

Official source
https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0593-2026%22
Source dataset
openFDA Drug Enforcement API
Publication date
2026-06-24
Ingested
2026-08-22
Record hash
cd14fe64a6796717

Verify every value against the official FDA source above. This site links to the regulator's record rather than replacing it.